Plexus (PLXS)
(Delayed Data from NSDQ)
$153.71 USD
-2.17 (-1.39%)
Updated Nov 14, 2024 04:00 PM ET
After-Market: $153.82 +0.11 (0.07%) 7:58 PM ET
1-Strong Buy of 5 1
B Value B Growth C Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$153.71 USD
-2.17 (-1.39%)
Updated Nov 14, 2024 04:00 PM ET
After-Market: $153.82 +0.11 (0.07%) 7:58 PM ET
1-Strong Buy of 5 1
B Value B Growth C Momentum B VGM
Zacks News
Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Celestica, Inc. (CLS) Soars to 52-Week High, Time to Cash Out?
by Zacks Equity Research
Celestica (CLS) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Surging Earnings Estimates Signal Upside for Plexus (PLXS) Stock
by Zacks Equity Research
Plexus (PLXS) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Why Plexus (PLXS) is a Top Momentum Stock for the Long-Term
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
New Strong Buy Stocks for October 30th
by Zacks Equity Research
CLPR, VLRS, SYF, IX and PLXS have been added to the Zacks Rank #1 (Strong Buy) List on October 30, 2024.
Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Plexus Q4 Earnings & Revenues Top Estimates, Rise Y/Y, Stock Gains
by Zacks Equity Research
PLXS' fiscal fourth-quarter performance gains from strength in the Aerospace/Defense and Industrial sectors.
Here's What Key Metrics Tell Us About Plexus (PLXS) Q4 Earnings
by Zacks Equity Research
Although the revenue and EPS for Plexus (PLXS) give a sense of how its business performed in the quarter ended September 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Plexus (PLXS) Surpasses Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Plexus (PLXS) delivered earnings and revenue surprises of 20.92% and 4.28%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Plexus Gearing Up to Report Q4 Earnings: Whats in the Cards?
by Zacks Equity Research
PLXS' fiscal fourth-quarter performance is likely to have benefited from new program wins and momentum in the Healthcare/Life Sciences and Industrial sectors.
Why Is Plexus (PLXS) Down 4.2% Since Last Earnings Report?
by Zacks Equity Research
Plexus (PLXS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Plexus (PLXS) Q3 Earnings Top Estimates, Revenues Decline Y/Y
by Zacks Equity Research
Plexus' (PLXS) fiscal third-quarter performance is affected by softness in the Healthcare/Life Sciences and Industrial sectors amid strength in the Aerospace/ Defense business.
Plexus (PLXS) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
Although the revenue and EPS for Plexus (PLXS) give a sense of how its business performed in the quarter ended June 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Plexus (PLXS) Tops Q3 Earnings Estimates
by Zacks Equity Research
Plexus (PLXS) delivered earnings and revenue surprises of 13.28% and 1.95%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Factors to Note Ahead of Plexus (PLXS) Q3 Earnings Release
by Zacks Equity Research
Plexus' (PLXS) fiscal third-quarter performance is likely to have benefited from new program ramps and rising demand for its solutions in the aerospace and defense vertical
Why Is Plexus (PLXS) Up 12.4% Since Last Earnings Report?
by Zacks Equity Research
Plexus (PLXS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Unlocking Plexus (PLXS) International Revenues: Trends, Surprises, and Prospects
by Zacks Equity Research
Examine the evolution of Plexus' (PLXS) overseas revenue trends and their effects on Wall Street's forecasts and the stock's prospects.
Plexus (PLXS) Q2 Earnings & Revenues Beat Estimates, Fall Y/Y
by Zacks Equity Research
Plexus's (PLXS) fiscal second-quarter performance is affected due to weakness in the Healthcare/Life Sciences and Industrial sectors.
Plexus (PLXS) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
by Zacks Equity Research
While the top- and bottom-line numbers for Plexus (PLXS) give a sense of how the business performed in the quarter ended March 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Plexus (PLXS) Q2 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Plexus (PLXS) delivered earnings and revenue surprises of 8.05% and 1.64%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Plexus (PLXS) to Report Q2 Earnings: Key Factors to Note
by Zacks Equity Research
Plexus's (PLXS) fiscal second-quarter performance is likely to have benefited from new program ramps and rising demand for its solutions in commercial aerospace.
Plexus (PLXS) Up 0.3% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Plexus (PLXS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Plexus (PLXS) Q1 Earnings & Revenues Miss Estimates, Fall Y/Y
by Zacks Equity Research
Plexus' (PLXS) first-quarter performance is affected due to weakness in the Healthcare/Life Sciences and Industrial sectors.
Plexus (PLXS) Reports Q1 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
The headline numbers for Plexus (PLXS) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Plexus (PLXS) Q1 Earnings and Revenues Miss Estimates
by Zacks Equity Research
Plexus (PLXS) delivered earnings and revenue surprises of -0.95% and 1%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?